A major Supreme Court case that threatens to remove financial aid for most HealthCare.gov customers could affect hospitals' bottom lines.» Read More
John Spinello, inventor of the 'Operation' board game, can't afford his own real-life surgery.
Complex benefits plan options from employers can leave workers unsure of how to choose. How do you know you are making the best decision?
Next IT is launching a smartphone app that uses artificial intelligence to help treat patients suffering from chronic diseases.
Amgen's CEO provided an answer to Dan Loeb's recent suggestion that the biotechnology company be split up. In short, he said, it doesn't make sense.
Swiss drugmaker Novartis reported better-than-expected results on Tuesday, as strong sales of new products helped offset the expiration of a key patent.
Pfizer earnings topped analysts' expectations on Tuesday, helped by demand for its cancer drugs and medicines in emerging markets.
Shares of Sanofi tumbled around 7.4 percent early on Tuesday after the French drugmaker reported weaker-than-expected Q3 sales.
Amgen reported better-than expected quarterly results and said it projects full-year earnings and revenue to come in above analysts' forecasts.
In a race to test antibodies that can unlock the mysteries of Ebola, Dr. Erica Saphire is crowdfunding her research to fast-forward efforts.
A nurse quarantined in NJ because of her contact with Ebola patients is headed to Maine, and a 5-year-old boy is being tested for the virus.
Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.
The roller coaster ride for Sarepta continues, as it's likely to file for approval of its muscular dystrophy drug in mid-2015.
Researchers say they have developed a test that can diagnose Ebola within 30 minutes, the BBC reports.
Mobile wallet Apple Pay has been available for only one week but may be inciting a battle in the payments industry. The NYT reports.
Merck reported earnings that beat analysts' expectations, but global sales dropped amid patent expirations and a drop in sales of its hep C drugs.
New Jersey Gov. Chris Christie mounted an impassioned defense of the decision to quarantine a healthcare worker who had contact with Ebola patients.
New York's Ebola case has investors wondering if there will be any economic impact from the scare. If trends in Dallas are any indication, there could be.
Drugmakers are racing to develop vaccines and drugs to address Ebola, betting that governments and aid groups will foot the bill.
Lawyers for a nurse quarantined in a N.J. hospital say they’ll sue to have her released in a constitutional challenge to state restrictions for health care workers.
New restrictions by Cuomo on travelers who had been in contact with Ebola victims are more in line with federal guidelines. NBC News reports.
Get the best of CNBC in your inbox